Don’t forget you can visit MyAlerts to manage your alerts at any time.
1,714 results for 'Mayer Brown/////////////////////////////////////////////////////// industry:"Insurance"' You can use Search Constraints to get even better search results
Publication Date: 2012-05-10
Practice Area:
Industry:
Court: Appellate Division, First Department
Judge: Before: Gonzalez, P.J., Tom, Saxe, Catterson, Richter, JJ.
Attorneys: For plaintiff: For Respondent: Eric T. Schneiderman, Attorney General, New York (Richard Dearing of counsel). For Amicus Curiae: Mayer Brown LLP, Washington, DC (Andrew J. Pincus of counsel).
for defendant: For Maurice R. Greenberg, Appellant: Boies, Schiller & Flexner LLP, Cambridge, MA (Charles Fried of the bar of the State of Massachusetts, admitted pro hac vice, of counsel), Boies, Schiller & Flexner LLP, Armonk (David Boies of counsel), and Morvillo, Abramowitz, Grand, Iason, Anello & Bohrer, P.C., New York (Robert G. Morvillo of counsel). For Howard I. Smith, Appellant: Kaye Scholer LLP, New York (Vincent A. Sama of counsel).
Case Number: 401720/05
Cite as: People v. Maurice Greenberg, 401720/05, NYLJ 1202552961392, at *1 (App. Div., 1st, Decided May 8, 2012)Before: Gonzalez, P.J., Tom, Saxe, Catters
May 31, 2010 | National Law Journal
LATERALS ALSTON & BIRD (Atlanta): Kate Moseley joins the firm's global finance practice as partner in the Dallas office and will focus on r
1 minute read
March 20, 2013 | National Law Journal
Plaintiffs' lawyers in proposed class actions cannot avoid federal courts by promising to seek less than $5 million in damages, according to a unanimous U.S. Supreme Court on Tues
1 minute read
Publication Date: 2012-03-28
Practice Area:
Industry:
Court: Supreme Court, New York County, Part 39
Judge: Justice Barbara R. Kapnick
Attorneys: For plaintiff: Plaintiff was represented by Andrew J. D'Arcy, Esq., D'Arcy Johnson Day, LLP, and Alison G. Greenberg, Esq., Law Office of Alison G. Greenberg.
for defendant: Defendants were represented by Nancy G. Eisner, Esq., Mayer Brown LLP.
Case Number: 104485/10
Cite as: Kelly v. Legacy Benefits Corp., 104485/10, NYLJ 1202547009263, at *1 (Sup., NY, Decided March 12, 2012)Justice Barbara R. Kapnickp class="de
March 21, 2013 | National Law Journal
WASHINGTON - Plaintiffs lawyers in proposed class actions cannot avoid federal courts by promising to seek less than $5 million in damages, according to a unanimous U.S. Supreme Court.
1 minute read
Publication Date: 2009-02-06
Practice Area:
Industry:
Court: Appellate Division, 4th Dept
Judge:
Attorneys: For plaintiff:
for defendant:
Case Number: 1415
SUPREME COURT OF THE STATE OF NEW YORK Appellate Division, Fourth Judicial Department 1415 CA 08-01085 PRESENT: HURLBUTT, J.P., MARTOCHE,
Publication Date: 2010-07-12
Practice Area:
Industry:
Date Filed: 2010-07-12
Court: Ca. Sup. Ct.
Judge:
Attorneys: For plaintiff: Attorneys for Appellant: Alioto Law Firm, Joseph M. Alioto, Joseph M. Alioto, Jr., Theresa D. Moore, Angelina Alioto-Grace, Thomas P. Pier; Law Offices of John H. Boone, John H. Boone; Foreman & Brasso, Russell F. Brasso; Law Offices of James M. Dombroski, James M. Dombroski; Law Offices of Jeffery K. Perkins, Jeffrey K. Perkins; Gary D. McCallister & Associates, Gary D. McCallister, Thomas A. Kelliher, Eric I. Unrein and Jaime Goldstein for Plaintiffs and Appellants.
Coughlin Stoia Geller Rudman & Robbins, Pamela M. Parker; Schubert Jonckheer Kolbe & Kralowec and Kimberly A. Kralowec for Consumer Attorneys of California as Amicus Curiae on behalf of Plaintiffs and Appellants.
Zelle Hofmann Voelbel & Mason, Craig C. Corbitt and Henry A. Cirillo for Pharmacists Planning Services, Inc., as Amicus Curiae on behalf of Plaintiffs and Appellants.
for defendant: Attorneys for Respondent: Filice Brown Eassa & McLeod, Peter A. Strotz, Paul R. Johnson, William E. Steimle; Davis Polk & Wardwell, Ameila Starr, Arthur F. Golden, William J. Fenrich and Daniel J. Schwartz for Defendant and Respondent AstraZeneca LP.
Winston & Strawn, Tyler M. Paetkau, Nicole P. Dogwill, James F. Hurst, Susan A. Pipal, Matthew J. Sullivan; Eimer Stahl Klevorn & Solberg, David M. Stahl, J. Cunyon Gordon and Adam Oyenbanji for Defendant and Respondent Abbott Laboratories.
Gibson, Dunn & Crutcher, Jeffrey T. Thomas and James N. Knight for Defendant and Respondent Allergan, Inc.
Mayer, Brown, Rowe & Maw, Mayer Brown, Donald M. Falk, John Nadolenco, Mack Anderson; Sheppard Mullin Richter & Hampton, Steven O. Kramer, John P. Stigi III; Hogan & Hartson and Joseph H. Young for Defendant and Respondent Amgen, Inc.
Covington & Burling, Elizabeth Abigail Brown, Anita F. Stork, Theodore Voorhees, Jr., and Thomas J. Cosgrove for Defendant and Respondent Boehringer Ingelheim Pharmaceuticals, Inc.
Sedgwick, Detert, Moran & Arnold, Paul J. Riehle, Matthew A. Fischer; Cravath, Swaine & Moore, Evan R. Chesler, Elizabeth L. Grayer, Jessica Buturla and Jeffrey B. Korn for Defendant and Respondent Bristol-Myers Squibb Company.
Reed Smith, Michael Diane Floyd, Kirsten J. Handelman; Oppenheimer Wolff & Donnelly, Gary Hansen, David Graham and Aaron Mills Scott for Defendant and Respondent Eli Lilly & Company.
Irell & Manella, Alexander F. Wiles, John C. Keith; Cleary Gottlieb Steen & Hamilton, George S. Cary, Sara D. Schotland and David I. Gelfand for Defendant and Respondent GlaxoSmithKline PLC.
Drinker Biddle & Reath, H. Christian L?Orange, Paul H. Saint-Antoine, Mary E. Kohart, David J. Antczak and Joanne C. Lewers for Defendant and Respondent Hoffmann-La Roche Inc.
Folger Levin & Kahn, Crowell & Moring, Beatrice Bich-Dao Nguyen, Samuel Ray Miller, Tracy E. Reichmuth, Cecilia C. Ogbu, Steven E. Wilson; Patterson Belknap Webb & Tyler, William Cavanaugh, Jr., and Cecilia B. Loving for Defendants and Respondents Janssen Pharmaceutica Inc., Johnson & Johnson Health Care Systems, Inc., Ortho Biotech, Inc., and Ortho-McNeil Pharmaceutical, Inc.
Hughes Hubbard & Reed, Rita M. Haeusler, John M. Townsend, Scott H. Christensen, James A. Graffam; Orrick, Herrington & Sutcliffe, Robert P. Reznick and David Goldstein for Defendant and Respondent Merck Sharp & Dohme Corp. formerly known as Merck & Co., Inc.
Kaye Scholer, Aton Arbisser, Bryant S. Delgadillo, Saul P. Morgenstern, Karin E. Garvey; Faegre & Benson, James A. O?Neal and Kim J. Walker for Defendant and Respondent Novartis Pharmaceuticals Corporation.
Nossaman, Gunther, Knox & Elliott, Nossaman, Scott DeVries, Katrina June Lee; Dickstein Shapiro, Peter J. Kadzik, Bernard Nash, Maria Colsey Heard, Milton Marquis and Andres Colin for Defendant and Respondent Pfizer Inc.
Latham & Watkins, Charles H. Samel, Jennifer A. Carmassi, Margaret M. Zwisler, Steven H. Schulman and Belinda S. Lee for Defendant and Respondent Pharmaceutical Research and Manufacturers of America.
Arnold & Porter, Ronald C. Redcay, Douglas L. Wald, Mark R. Merley, Daniel R. Waldman, Anne P. Davis and Ryan Z. Watts for Defendant and Respondent Wyeth.
Case Number: No. S166435
Cite as 10 C.D.O.S. 87895JAMES CLAYWORTH et al., Plaintiffs and Appellants, v. PFIZER, INC., et al., Def
October 1, 2012 | National Law Journal
With its blockbuster health care, immigration and other high-profile decisions, the U.S. me Court's last term would seem hard to rival, but the new term may do just that. "The
1 minute read
October 10, 2012 | The Legal Intelligencer
When a company collapses and creditors or a trustee are looking to recoup losses, banks and accounting firms have often been targeted under the theory that it was their advice or their ignora
1 minute read
October 12, 2012 | The American Lawyer
Akin Gump Strauss Hauer & Feld raided Haynes and Boone's Dallas office this week, picking up a seven-partner group of corporate and litigation attorneys for its own Dallas operatio
1 minute read
Legal Speak is a weekly podcast that makes sense of what’s happening in the legal industry.
